ferric ferrocyanide has been researched along with citric acid, anhydrous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheong, KK; Kang, Y; Wu, Y; Xue, P | 1 |
Ebert, M; Genter, G; Kratz, H; Mueller, S; Scharlach, C; Schellenberger, E; Schnorr, J; Warmuth, C; Wiekhorst, F | 1 |
2 other study(ies) available for ferric ferrocyanide and citric acid, anhydrous
Article | Year |
---|---|
An in-vitro study of enzyme-responsive Prussian blue nanoparticles for combined tumor chemotherapy and photothermal therapy.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Citric Acid; Doxorubicin; Drug Carriers; Drug Liberation; Enzyme Activation; Ferrocyanides; Gelatin; Gelatinases; Hepatocytes; Humans; Kinetics; Lasers; Nanoparticles; Phototherapy | 2015 |
Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining.
Topics: Animals; Aorta; Apolipoproteins E; Carotid Arteries; Citric Acid; Etidronic Acid; Ferric Compounds; Ferrocyanides; Magnetic Resonance Imaging; Magnetite Nanoparticles; Malates; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Plaque, Atherosclerotic; Spectrum Analysis; Staining and Labeling; Tartrates | 2015 |